Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Clasificación en acciones #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Precio por acción
$0.106
Última sincronización: 2026-10-01
Capitalización bursátil
$767.67K
Cambio (1 día)
73.77%
Cambio (1 año)
-84.81%
País
US
Comercio Mosaic ImmunoEngineering Inc. (CPMV)

Categoría

Ganancias de Mosaic ImmunoEngineering Inc. (CPMV)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Mosaic ImmunoEngineering Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Mosaic ImmunoEngineering Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -
US
$-3.09B -
US
$-4.02B -
AU
$1.95B -
NL
- -
CH